Considering the infiltrating immune cells in the tumor areas, we could not entirely exclude the contribution of the ST3GAL5 expression in non-tumor cells to the conclusion on its overexpression in the ccRCCs by the transcriptomic data in TCGA-BLCA and GEO datasets alone. The gene discussed is ST3GAL5; the disease is neoplasm.